GLP-1 Face in Singapore: Facial Volume Loss and Skin Laxity After Weight Loss

GLP-1 Face in Singapore: Facial Volume Loss and Skin Laxity After Weight Loss

Written and medically reviewed by Dr Rachel Ho, MBBS, MMed
Founder of The Skin Longevity Clinic, Singapore
Last reviewed August 2026

GLP-1 face is an informal term for facial hollowing, deeper folds and loose skin that may become visible during substantial weight loss associated with GLP-1 based treatment. The main change appears to be loss of facial fat and tissue support, while possible direct effects of these medicines on skin biology remain under investigation1,2.

Treatment depends on what has changed. Localised fat loss, diffuse facial deflation, skin laxity, dynamic wrinkles and surface dryness require different approaches, so a treatment should be chosen according to anatomy rather than the label GLP-1 face.

GLP-1 face at a glance

What is GLP-1 face?

Facial hollowing, deeper folds and skin laxity that may become visible during substantial weight loss

What causes it?

Loss of facial fat and reduced support beneath the skin appear to be the main contributors

Which areas change most?

Temples, under eyes, cheeks, jawline and neck

Can GLP-1 facial changes be prevented?

Medical supervision and preservation of muscle and skin health may reduce visible severity, but complete prevention cannot be guaranteed

Do GLP-1 facial changes go away?

Early dryness or mild changes may improve after weight stabilises, while established fat loss and excess skin may remain

Early dryness or mild changes may improve after weight stabilises, while established fat loss and excess skin may remain

Assessment can begin during weight loss, while definitive correction is often easier once weight is relatively stable

What treatments may help GLP-1 facial changes?

Fillers, collagen biostimulators, radiofrequency tightening, RF microneedling, skin quality treatments and, for marked excess skin, surgery

Should medication be stopped for GLP-1 facial changes?

Medication decisions should remain with the prescribing doctor and should not be changed solely for cosmetic reasons

What is GLP-1 face?


The phrase describes a pattern rather than a formal medical diagnosis. Similar facial changes can occur after bariatric surgery, restrictive dieting, illness or any other form of substantial weight loss.

Facial fat is arranged in superficial and deep compartments that support the cheeks, temples, eyelids and lower face. When these compartments become smaller, the skin has less underlying support, which can make folds, shadows and laxity more visible1,3.

What does the research on GLP-1 facial changes show?


A 2025 imaging study of 20 patients found a median reduction of approximately 9 percent in total midfacial volume during GLP-1 associated weight loss. The researchers estimated an average reduction of 7 percent in midfacial volume for each 10 kilograms of weight lost, with much of the change occurring in the superficial fat compartments1.

This was a small retrospective study, so the figures should not be treated as a prediction for every patient. Age, baseline facial fullness, total weight lost, speed of weight change and individual skin elasticity can all influence the visible result.

Is GLP-1 face caused by the medicine or the weight loss?


Substantial and rapid fat loss appears to be the main explanation. The same facial changes can occur after other forms of major weight reduction, which supports the role of fat loss and reduced tissue support.

Researchers are also studying whether GLP-1 based medicines have additional effects on adipose tissue, fibroblasts or skin ageing pathways. These possible direct effects remain less certain than the anatomical effects of weight loss itself.2,3

Common signs of GLP-1 face

Area Possible change Main contributor
Temples Concavity or a more skeletal upper face Loss of temporal fat
Under eyes Deeper tear troughs and more visible shadows Reduced cheek and periorbital support
Cheeks Flattening or hollowing Superficial and deep fat loss
Nasolabial folds Folds may appear deeper Reduced midface support
Jawline Jowls or loss of jawline definition Volume loss combined with laxity
Neck Looser skin or more visible bands Reduced elasticity and tissue support
Skin surface Dryness, fine lines or dullness Nutritional change, barrier disruption and reduced support

Periorbital changes may make eye bags or dark circles look more prominent even when the eye bags themselves have not increased. Recent reviews describe under eye hollowing and altered eyelid support after GLP-1 associated weight loss, although much of the evidence remains observational4.

Who is more likely to notice facial changes after starting GLP-1 agonist medications?


Facial changes tend to be more visible when weight loss is substantial, occurs quickly or begins in a face that is already lean. Reduced skin elasticity, existing temple or cheek hollowing and previous facial ageing can also make the change more apparent.

Two people who lose the same amount of weight may therefore look very different afterwards. Facial anatomy and baseline tissue distribution are more informative than body weight alone.

Can GLP-1 face be prevented?


A guaranteed method for preserving facial fat during weight loss has not been established. Medical supervision, an appropriate pace of weight reduction, adequate protein intake, resistance training, sleep and regular review may help preserve lean tissue and support overall recovery, but they cannot ensure that facial fat will remain unchanged.5

Daily sunscreen, moisturiser and a tolerated retinoid or antioxidant may support skin quality. Skincare cannot prevent loss of the deeper facial fat that gives the cheeks and temples their shape.

Patients should discuss weight loss speed, side effects and nutritional concerns with their prescribing doctor. A medication dose or treatment plan should not be changed solely because of a cosmetic facial concern.

Does GLP-1 face go away?


Mild dryness, dehydration and some early skin changes may improve once nutrition, hydration and weight become more stable. Established facial fat loss and significant excess skin may persist because the lost tissue does not reliably return on its own.

Weight regain can restore some facial fullness, but the distribution is unpredictable and weight gain should not be used as an aesthetic treatment. An assessment after the weight trajectory becomes clearer helps distinguish changes that may settle from those that are likely to need correction.

When should treatment begin for GLP-1 facial changes?


Assessment can begin while weight loss is continuing. Early review can document baseline facial volume, identify rapid changes and establish a skincare and muscle preservation plan.

Definitive volumisation is often more predictable once body weight is relatively stable. Treating during rapid ongoing loss may lead to repeated correction because the facial structure is still changing5.

Earlier treatment may still be considered when hollowing is causing significant concern or when the weight loss trajectory is gradual and medically supervised. The plan should remain conservative and staged.

How GLP-1 face is assessed at The Skin Longevity Clinic


Dr Rachel Ho assesses the face by separating four components:

  1. Volume loss, including the temples, under eyes, cheeks and lower face
  2. Skin laxity, including the jawline and neck
  3. Movement related lines, including forehead lines and crow’s feet
  4. Skin quality, including dryness, texture, fine lines and reduced resilience

The assessment also considers previous fillers, energy treatments, current weight trajectory, medical history, nutrition and how much change the patient wants. This follows the clinic’s wider skin longevity framework of identifying what should be treated, what can wait and whether the tissue is ready for a procedure.

Treatment options for GLP-1 face in Singapore

Hyaluronic acid fillers for localised volume loss

Hyaluronic acid fillers can restore volume to selected areas such as the temples, cheeks or parts of the lower face. Their effect is visible immediately, although the final result is assessed after swelling settles.

Fillers are useful when precise contour restoration is required. They can generally be reduced with hyaluronidase, which may be relevant for patients who value reversibility.

Treatment should remain conservative because adding volume indiscriminately can make the face look heavy or disproportionate. Risks include swelling, bruising, infection, asymmetry, nodules and rare vascular complications.

Collagen biostimulators for diffuse tissue support

Collagen biostimulators may suit broader facial deflation, reduced firmness and gradual loss of tissue support. These injectables encourage collagen remodelling over several weeks to months rather than producing only immediate gel volume.

Results develop progressively and cannot be adjusted as easily as a hyaluronic acid filler. Product choice, dilution, injection plane and anatomical distribution all influence the result.

A 2026 open label study of 41 patients with GLP-1 associated facial changes reported improvements after a staged combination of PLLA collagen biostimulation and hyaluronic acid filler. The study had no untreated control group and evaluated a product specific protocol, so it supports a possible treatment approach rather than establishing one universal standard6.

Radiofrequency tightening for mild to moderate laxity

Radiofrequency treatment may improve mild to moderate laxity along the cheeks, jawline and neck by heating selected tissue layers and stimulating collagen remodelling. The Skin Longevity Clinic offers XERF as one radiofrequency option for appropriately selected patients.

Radiofrequency does not restore lost facial fat. A hollow face may require volume assessment before tightening because contraction alone can make deflation look more apparent.

Radiofrequency microneedling for texture and fine lines

Radiofrequency microneedling may help with fine lines, pores, texture and selected early laxity. It works within the skin rather than replacing deeper facial volume, so it is usually considered for surface quality and collagen support.
Evidence for microneedling based facial rejuvenation is encouraging, although treatment schedules and outcome measurements vary considerably between studies.7

Skin boosters for hydration and skin quality

Hyaluronic acid, ECM and PDRN based skin boosters may improve hydration, fine texture and skin resilience. They may be useful when weight loss has left the skin looking dry, crepey or less luminous.

Skin boosters do not replace lost cheek or temple fat and cannot lift marked jowling. Their role is skin quality rather than structural volume restoration.

Movement focused treatment for dynamic wrinkles

Forehead lines, frown lines, crow’s feet and selected neck bands may become more visible after facial volume loss. Movement focused treatment can soften these dynamic lines but does not correct hollowing or loose skin.

The dose and placement should account for brow position, facial support and the patient’s natural expression. Wrinkle treatment should therefore be planned as a separate component of the face rather than used as a substitute for volume restoration.

Surgical assessment for significant excess skin

Substantial jowls, advanced neck laxity or considerable excess skin may exceed what injectable and energy based treatments can achieve. A surgical consultation may provide a more appropriate option when the goal requires removal or repositioning of tissue.

A responsible nonsurgical assessment should make this limitation clear. Repeated procedures should not be used to postpone a surgical discussion when surgery is more likely to address the anatomical problem.

A staged treatment sequence

Stage Main priority
During active weight loss Medical monitoring, nutrition, muscle preservation, sunscreen and barrier care
Approaching weight stability Facial assessment and documentation of persistent changes
Structural treatment Restore selected volume where it is genuinely deficient
Laxity treatment Add radiofrequency or another collagen remodelling option where suitable
Skin quality treatment Address dryness, fine texture and resilience
Maintenance Review weight, facial balance, skincare and treatment intervals

The sequence may differ for an individual patient. Restoring support before tightening can be more appropriate when hollowing is prominent, while a patient with adequate facial volume and mild laxity may begin with radiofrequency.

What treatment cannot promise

Aesthetic treatment cannot guarantee that the face will look exactly as it did before weight loss. Facial proportions, age related change and the degree of tissue loss influence what can be restored.

Skincare cannot rebuild lost facial fat, and nonsurgical tightening cannot reproduce a facelift. Collagen biostimulators and fillers also cannot prevent further change when weight is continuing to fall rapidly.

Possible side effects and risks

Injectable treatments can cause swelling, bruising, tenderness, asymmetry, infection and nodules. Accidental injection into a blood vessel is rare but can cause skin injury and, in exceptional cases, visual complications8.

Energy based treatments can cause temporary redness, swelling, tenderness, burns, pigment change or unwanted changes in facial fat when patient selection or settings are unsuitable. Skin boosters and microneedling may also cause short term bumps, bruising, redness or irritation.

A consultation should cover expected reactions, material risks, alternatives and the plan for follow up before treatment begins.

Dr Rachel Ho’s clinical perspective on GLP-1 face treatments in Singapore

I assess GLP-1 face by separating volume loss, laxity, movement and skin quality. Tightening a face that has lost substantial support may accentuate hollowing, while adding volume without addressing laxity can leave the result heavy.

Treatment is therefore staged according to anatomy and the patient’s weight trajectory. The aim is to restore balance without recreating every millimetre of volume that has been lost.

GLP-1 face treatment at The Skin Longevity Clinic

Dr Rachel Ho is the founder of The Skin Longevity Clinic and has more than 16 years of clinical experience in Singapore. Her work combines skin biology, facial anatomy and longer term treatment planning, with an emphasis on refined rather than obvious change.

The Skin Longevity Clinic is located at 9 Scotts Road, #06-05 Scotts Medical Center at Pacific Plaza, Singapore 228210, near Orchard Road.

Book a Consultation

FAQs

Is GLP-1 face a medical diagnosis?

The term is informal rather than a recognised medical diagnosis. It describes visible facial changes associated with substantial weight loss, including hollowing, deeper folds and skin laxity.

Does everyone develop GLP-1 face?

Many patients do not develop noticeable facial changes. The visible result depends on the amount and speed of weight loss, baseline facial anatomy, skin elasticity and age related tissue changes.

Can GLP-1 face be prevented completely?

A guaranteed prevention method has not been established. Medically supervised weight loss, adequate nutrition, resistance training and good skin care may support overall tissue health but cannot ensure that facial fat will remain unchanged.

Does GLP-1 face improve after weight stabilises?

Some dryness and early changes may soften after weight stabilises. Persistent fat loss, hollowing or marked excess skin may remain and require a diagnosis specific treatment plan.

Should treatment wait until weight loss is complete?

Assessment can begin during weight loss, while more definitive volumisation is usually easier to plan after the weight has become relatively stable. Earlier conservative treatment may still be reasonable in selected patients.

Are fillers or collagen biostimulators better?

The better choice depends on the treatment goal. Hyaluronic acid filler is useful for immediate, precise and reversible correction, while collagen biostimulators create slower and more diffuse tissue support.

Can skincare treat GLP-1 face?

Skincare can improve dryness, pigmentation, fine texture and barrier function. It cannot replace lost facial fat or remove significant loose skin.

Can radiofrequency tighten GLP-1 face?

Radiofrequency may improve mild to moderate skin laxity. It does not replace lost volume and should be planned carefully when the face already appears hollow.

Should I stop my medication because my face looks different?

Medication decisions should be discussed with the prescribing doctor. Cosmetic facial changes should not lead to stopping or altering medically indicated treatment without clinical review.

How much does GLP-1 face treatment cost in Singapore?

Cost depends on whether treatment involves fillers, collagen biostimulators, radiofrequency, RF microneedling, skin boosters or a staged combination. A complete quotation can be provided after the areas and treatment priorities have been assessed.

References

  1. Sharma RK, et al. Radiographic Midfacial Volume Changes in Patients on GLP-1 Receptor Agonists. 2025. PMID 40407186.
  2. Paschou IA, et al. GLP-1 Receptor Agonists and Possible Skin Ageing. 2025. PMID 40498168.
  3. Daneshgaran G, et al. A Systematic Review of GLP-1 Receptor Agonists and Their Aesthetic Effects. 2025. PMID 40626110.
  4. Kapantais D, et al. Functional and Aesthetic Periorbital Changes Associated With GLP-1 Based Treatment. 2025. PMID 41464694.
  5. Nikolis A, et al. Consensus Statements on Managing Aesthetic Needs During Medication Driven Weight Loss. 2025. PMID 40135477.
  6. Lorenc ZP, et al. Combined PLLA and Hyaluronic Acid Treatment of GLP-1 Related Facial Changes. 2026. PMID 41243519.
  7. Foppiani JA, et al. Microneedling for Facial Rejuvenation: A Systematic Review. 2025. PMID 40542236.
  8. Doyon VC, et al. Update on Blindness From Aesthetic Filler Injection. Aesthetic Surgery Journal. 2024. PMID 38630871.